Healome Therapeutics is a healthcare company that develops treatments for ocular surface diseases.
Healome Therapeutics has raised $2.7M in total funding. The most recent round was Seed. The last funding was announced in July 2026.
Healome Therapeutics's investors include SFC Capital, Empirical Ventures, Oshen, DEBRA Research, Cure EB.
Healome Therapeutics is headquartered in Birmingham, United Kingdom.
Healome Therapeutics is a healthcare company that develops treatments for ocular surface diseases.
Healome Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Healome Therapeutics — Funding & Investors." VCBacked, July 7, 2026, https://www.vcbacked.co/company/healome-therapeutics. Accessed September 29, 2026.
VCBacked. (2026). Healome Therapeutics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/healome-therapeutics
{{cite web |title=Healome Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/healome-therapeutics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated